You’ve hit your search limit
Start your free trial to keep exploring full traffic and performance insights.
Get StartedCogEval analisi dell'app per 12 gennaio
CogEval
- Biogen Inc.
- App Store di Apple
- Gratis
- Salute e fitness
CogEval is an iPad-based assessment designed to evaluate cognitive function in patients with multiple sclerosis (MS). It provides a two-minute Processing Speed Test (PST) that evaluates cognitive function using elements of attention, psychomotor speed, visual processing and working memory. CogEval is based on, and validated against, the Symbol Digit Modalities Test (SDMT). During the two-minute assessment, the patient pairs abstract symbols with numbers, using a key as a guide. Upon completion, the summary, normed data is available for review by healthcare professionals.
CogEval is intended for use in the healthcare setting and is available only to healthcare providers with responsibility for the management of people with MS. CogEval is reset after each use; the patient information and test results are not stored within the App.
CogEval is supported on iPads 5th generation of later with a screen size of 9.7" (24.6 cm) or greater on iOS 13 or greater. iPad minis are not supported.
Classifica degli store
La classifica del store si basa su diversi parametri stabiliti da Google e Apple.
Tutte le categorie in
Stati Uniti--
Salute e fitness in
Stati Uniti--
Crea un account per visualizzare il numero mensile medio di downloadContattaci
CogEvalStatistiche di ranking nel tempo
Classifica di Utilizzo di Similarweb e Classifica App Store di Apple per CogEval
Rank
Nessun dato disponibile
CogEval Classifica per paese
Paesi in cui CogEval ha la posizione più alta nelle sue categorie principali
Nessun dato da visualizzare
Principali concorrenti e app alternative
App con un'alta probabilità di essere utilizzate dagli stessi utenti, provenienti dallo stesso store.
MSPT
Qr8 Health Inc.
Neuro65/AOCN2024
Japanese Society of Neurology
TabCAT
University of California at San Francisco
Cognition Snapshot +
Qr8 Health Inc.
gennaio 12, 2026